Supplementation with the Probiotic Strains Bifidobacterium longum and Lactiplantibacillus rhamnosus Alleviates Glucose Intolerance by Restoring the IL-22 Response and Pancreatic Beta Cell Dysfunction in Type 2 Diabetic Mice
- PMID: 37804432
- DOI: 10.1007/s12602-023-10156-5
Supplementation with the Probiotic Strains Bifidobacterium longum and Lactiplantibacillus rhamnosus Alleviates Glucose Intolerance by Restoring the IL-22 Response and Pancreatic Beta Cell Dysfunction in Type 2 Diabetic Mice
Abstract
Type 2 diabetes (T2D) is known as adult-onset diabetes, but recently, T2D has increased in the number of younger people, becoming a major clinical burden in human society. The objective of this study was to determine the effects of Bifidobacterium and Lactiplantibacillus strains derived from the feces of 20 healthy humans on T2D development and to understand the mechanism underlying any positive effects of probiotics. We found that Bifidobacterium longum NBM7-1 (Chong Kun Dang strain 1; CKD1) and Lactiplantibacillus rhamnosus NBM17-4 (Chong Kun Dang strain 2; CKD2) isolated from the feces of healthy Korean adults (n = 20) have anti-diabetic effects based on the insulin sensitivity. During the oral gavage for 8 weeks, T2D mice were supplemented with anti-diabetic drugs (1.0-10 mg/kg body weight) to four positive and negative control groups or four probiotics (200 uL; 1 × 109 CFU/mL) to groups separately or combined to the four treatment groups (n = 6 per group). While acknowledging the relatively small sample size, this study provides valuable insights into the potential benefits of B. longum NBM7-1 and L. rhamnosus NBM17-4 in mitigating T2D development. The animal gene expression was assessed using a qRT-PCR, and metabolic parameters were assessed using an ELISA assay. We demonstrated that B. longum NBM7-1 in the CKD1 group and L. rhamnosus NBM17-4 in the CKD2 group alleviate T2D development through the upregulation of IL-22, which enhances insulin sensitivity and pancreatic functions while reducing liver steatosis. These findings suggest that B. longum NBM7-1 and L. rhamnosus NBM17-4 could be the candidate probiotics for the therapeutic treatments of T2D patients as well as the prevention of type 2 diabetes.
Keywords: Bifidobacterium longum; IL-22; Insulin sensitivity; Lactiplantibacillus rhamnosus; Type 2 diabetes (T2D).
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Similar articles
-
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice.Gut Microbes. 2024 Jan-Dec;16(1):2319889. doi: 10.1080/19490976.2024.2319889. Epub 2024 Feb 23. Gut Microbes. 2024. PMID: 38391178 Free PMC article.
-
Role of Lactiplantibacillus plantarum UBLP-40, Lactobacillus rhamnosus UBLR-58 and Bifidobacterium longum UBBL-64 in the Wound Healing Process of the Excisional Skin.Nutrients. 2023 Apr 10;15(8):1822. doi: 10.3390/nu15081822. Nutrients. 2023. PMID: 37111041 Free PMC article.
-
Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.World J Gastroenterol. 2017 Apr 21;23(15):2696-2704. doi: 10.3748/wjg.v23.i15.2696. World J Gastroenterol. 2017. PMID: 28487606 Free PMC article. Clinical Trial.
-
Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis.Eur J Clin Pharmacol. 2017 Oct;73(10):1199-1208. doi: 10.1007/s00228-017-2291-6. Epub 2017 Jul 5. Eur J Clin Pharmacol. 2017. PMID: 28681177 Review.
-
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Endocrine. 2017 Nov;58(2):207-227. doi: 10.1007/s12020-017-1433-z. Epub 2017 Oct 19. Endocrine. 2017. PMID: 29052181 Review.
Cited by
-
Beneficial Effects of Probiotic Lactobacillus paraplantarum BGCG11 on Pancreatic and Duodenum Function in Diabetic Rats.Int J Mol Sci. 2024 Jul 13;25(14):7697. doi: 10.3390/ijms25147697. Int J Mol Sci. 2024. PMID: 39062940 Free PMC article.
-
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice.Gut Microbes. 2024 Jan-Dec;16(1):2319889. doi: 10.1080/19490976.2024.2319889. Epub 2024 Feb 23. Gut Microbes. 2024. PMID: 38391178 Free PMC article.
-
Real-time PCR methods for identification and stability monitoring of Bifidobacterium longum subsp. longum UABl-14 during shelf life.Front Microbiol. 2024 Apr 19;15:1360241. doi: 10.3389/fmicb.2024.1360241. eCollection 2024. Front Microbiol. 2024. PMID: 38706967 Free PMC article.
References
-
- Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88–98. https://doi.org/10.1038/nrendo.2017.151 - DOI - PubMed
-
- Wang X, Yang J, Qiu X, Wen Q, Liu M, Zhou D et al (2021) Probiotics, pre-biotics and synbiotics in the treatment of pre-diabetes: a systematic review of randomized controlled trials. Front Public Health 9:645035. https://doi.org/10.3389/fpubh.2021.645035 - DOI - PubMed - PMC
-
- Mambiya M, Shang M, Wang Y, Li Q, Liu S, Yang L et al (2019) The play of genes and non-genetic factors on type 2 diabetes. Front Public Health 7:349. https://doi.org/10.3389/fpubh.2019.00349 - DOI - PubMed - PMC
-
- Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B (2014) Metformin: from mechanisms of action to therapies. Cell Metab 20(6):953–966. https://doi.org/10.1016/j.cmet.2014.09.018 - DOI - PubMed
-
- Bösenberg LH, van Zyl DG (2014) The mechanism of action of oral antidiabetic drugs: a review of recent literature. J Endocrinol Metab Diabetes S Afr 13(3):80–88. https://doi.org/10.1080/22201009.2008.10872177 - DOI
LinkOut - more resources
Full Text Sources